{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-06-B\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=B\n|Heading=Antipsychotics: knowledge of frequent or serious adverse effects, main drug interactions at all stages of life, particularly in elderly patients.\n|Description=None\n|Rubric=Management\n|Contributors=Louise Carton,Florian Naudet,Marie Tournier\n|Order=6}}\n\n==Frequent adverse reactions==\n\n===Psychiatric adverse reactions===\n\n*A state of psychomotor indifference\n*Post-psychotic depressive episode\n*Sedation\n*Confusion (especially when combined with other drugs in the elderly)\n\n===Neurological adverse reactions===\n\n*Dystonia (dyskinesias)\n*Parkinsonian syndrome\n*Hyperkinetic syndrome, akathisia\n*Late dyskinesias\n*Epileptic seizures\n*Risk of stroke in elderly subjects with dementia\n\n===Endocrine and Metabolic Adverse Reactions===\n\n*Weight gain\n*Lipid disorders\n*Diabetes\n*Metabolic syndrome\n*Hyperprolactinaemia, endocrine and sexual disorders\n\n===Neurovegetative and cardiovascular adverse effects===\n\n*Anticholinergic or atropinic effects\n*Orthostatic hypotension\n*QT prolongation, rhythm disorders and sudden death\n\n===Allergic and toxic side effects===\n\n*Allergy\n*Drug-induced agranulocytosis (particularly high with clozapine)\n*Photosensitisation and retinal and crystalline pigment deposits\n\n==Neuroleptic malignant syndrome==\nA '''<u>rare and serious</u>''' adverse effect, neuroleptic malignant s''yndrome''' has been described with '''most molecules''' and '''involves the vital prognosis'''. It is a diagnostic and therapeutic emergency.\n\n====On the clinical plan====\nIt has a rapidly progressive onset:\n\n*Hyperthermia (40-41\u00b0)\n*Extrapyramidal rigidity\n*Profuse sweating\n*Tachycardia\n*Hypotension\n*Impaired alertness\n*Cardiorespiratory disorders\n*Possible convulsions\n\n====Biological plan====\n\n*Hyperleukocytosis\n*Various ionogram disturbances\n*Increase in CPK, LDH, ALT and ASAT.\n\n==Main drug interactions==\n\n*QT-prolonging drugs\n*Dopaminergic agonists\n*First-generation antihistamines",
  "question": {
    "question": "What is the correct description of neuroleptic malignant syndrome (NMS) as it relates to antipsychotic medication?",
    "option_a": "A common and mild side effect that rarely impacts patient health.",
    "option_b": "A rare and serious adverse effect that can involve vital prognosis and requires immediate medical attention.",
    "option_c": "An allergic reaction that occurs frequently with all antipsychotic medications.",
    "option_d": "A state of psychomotor indifference that is typically observed in elderly patients.",
    "correct_option": "b"
  }
}